Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Arecor Therapeutics PLC ( (GB:AREC) ) has shared an update.
Arecor Therapeutics plc has announced significant changes to its Board, appointing Simon Ormiston as a Non-Executive Director and Chair of the Audit & Risk Committee, and elevating David Ellam, the Chief Financial Officer, to an Executive Director role. These changes are part of a strategic plan to strengthen the company’s governance and support its growth ambitions in the life sciences sector, particularly as it pursues strategic collaborations and monetization agreements.
The most recent analyst rating on (GB:AREC) stock is a Hold with a £68.00 price target. To see the full list of analyst forecasts on Arecor Therapeutics PLC stock, see the GB:AREC Stock Forecast page.
Spark’s Take on GB:AREC Stock
According to Spark, TipRanks’ AI Analyst, GB:AREC is a Neutral.
Arecor Therapeutics PLC’s stock is buoyed by strong technical indicators and positive corporate events, despite financial challenges typical of early-stage biotech companies. The technical analysis and corporate events significantly contribute to the overall score, highlighting market confidence and strategic growth initiatives.
To see Spark’s full report on GB:AREC stock, click here.
More about Arecor Therapeutics PLC
Arecor Therapeutics plc is a clinical stage biopharmaceutical company based in Cambridge, UK, focusing on drug development and delivery for diabetes and other cardiometabolic diseases. The company leverages its proprietary Arestat® technology platform to develop a portfolio of proprietary products and collaborates with leading pharmaceutical and biotechnology companies to enhance therapeutic products. Its lead product, AT278, is an ultra-concentrated, ultra-rapid acting insulin, and the company is also developing a novel oral delivery platform for peptides targeting the obesity and diabetes markets.
Average Trading Volume: 59,805
Technical Sentiment Signal: Buy
Current Market Cap: £32.66M
Learn more about AREC stock on TipRanks’ Stock Analysis page.